Patents by Inventor Matti Karp

Matti Karp has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 8993281
    Abstract: The present invention relates to a genetically modified Acinetobacter host for lipid production. The Acinetobacter host has been genetically modified to be deficient of one or more of genes A) a gene encoding fatty acyl-CoA reductase (EC1.2.1.n2), wherein said host is capable of increased production of TAGs and/or of total lipids compared to the parent host; and/or B) a gene encoding lipase (EC:3.1.1.3), a gene encoding pyruvate dehydrogenase (EC:1.2.2.2), and/or gene ACIAD 2177, or functional equivalents of any of said genes, wherein said host is capable of increased production of wax esters and/or total lipids compared to the parent host.
    Type: Grant
    Filed: December 15, 2011
    Date of Patent: March 31, 2015
    Assignee: Neste Oil Oyj
    Inventors: Suvi Myllyntausta, Virpi Kivinen, Antti Larjo, Tommi Aho, Perttu Koskinen, Matti Karp, Ville Santala
  • Publication number: 20120151833
    Abstract: The present invention relates to a genetically modified Acinetobacter host for lipid production. The Acinetobacter host has been genetically modified to be deficient of one or more of genes A) a gene encoding fatty acyl-CoA reductase (EC1.2.1.n2), wherein said host is capable of increased production of TAGs and/or of total lipids compared to the parent host; and/or B) a gene encoding lipase (EC:3.1.1.3), a gene encoding pyruvate dehydrogenase (EC:1.2.2.2), and/or gene ACIAD 2177, or functional equivalents of any of said genes, wherein said host is capable of increased production of wax esters and/or total lipids compared to the parent host.
    Type: Application
    Filed: December 15, 2011
    Publication date: June 21, 2012
    Applicant: NESTE OIL OYJ
    Inventors: Suvi Myllyntausta, Virpi Kivinen, Antti Larjo, Tommi Aho, Perttu Koskinen, Matti Karp, Ville Santala
  • Publication number: 20040259167
    Abstract: The invention relates to an isolated osteocalcin fragment derived from human urine, said fragment being characterized in that at least one of the glutamic acids in the position 17, 21 and 24 of the amino acid sequence 1                     6   7 Tyr-Leu-Tyr-Gln-Trp-Leu-Gly-Ala-Pro-Val-Pro-Tyr-                 17              21          24 Pro-Asp-Pro-Leu-Glu-Pro-Arg-Arg-Glu-Val-Cys-Glu-                   30 Leu-Asn-Pro-Asp-Cys-Asp-Glu-Leu-Ala-Asp-His-Ile- Gly-Phe-Gln-Glu-Ala-Tyr-Arg-Arg-Phe-Tyr-Gly-Pro- Val
    Type: Application
    Filed: July 22, 2004
    Publication date: December 23, 2004
    Inventors: Jukka Hellman, Sanna-Maria Kakonen, Matti Karp, Timo Lovgren, H. Kalervo Vaananen, Kim Pettersson
  • Patent number: 6475719
    Abstract: The invention relates to a method for determining a factor affecting a cell, which affects directly or indirectly the DNA, RNA and/or proteins of the cell or their synthesis machinery, in which recombinant DNA plasmid is transferred into the cell, and the initial point or points of the reproducing machinery responsible for its replication are subject to an adjustable promoter, which is controllable either by positive or negative feedback; the cell containing the recombinant DNA plasmid is brought into contact with the affecting factor; the affecting factor is allowed to affect the cell containing the recombinant DNA plasmid for a suitable time, after which the promoter adjusting the starting point of the reproducing machinery responsible for the replication of the recombinant DNA plasmid starts growing in the cell, unless the affecting factor has not inhibited the replication of the plasmid; the shift of the copy number of the recombinant DNA plasmid in the cell is determined directly or indirectly.
    Type: Grant
    Filed: October 21, 1991
    Date of Patent: November 5, 2002
    Assignee: Bio-Orbit Oy
    Inventors: Matti Karp, Matti Korpela
  • Patent number: 5776681
    Abstract: The invention relates to a method for determining a metal present in a sample, in which methoda) a recombinant DNA plasmid the copy number of which is under the control of a promoter regulatable by the metal is transferred into the cell, or a recombinant DNA plasmid the copy number of which can be varied between 1 and 2000/cell is transferred into the cell, and the plasmid contains as a marker protein a DNA sequence coding for a virus, procaryotic cell or eucaryotic cell protein or for a portion thereof essential for its biological activity, the expression of the DNA sequence being under the control of a promoter regulatable by the metal and being controlled by negative and/or positive feedback;b) the cell containing the recombinant DNA plasmid is contacted with a metal-containing sample;c) the metal is allowed to affect for a suitable time the cell which contains the recombinant DNA plasmid, whereafter the amount of recombinant DNA plasmid or the amount of protein encoded by it is determined by either physic
    Type: Grant
    Filed: September 15, 1995
    Date of Patent: July 7, 1998
    Inventors: Marko Virta, Matti Karp